“In GC, CBR3-AS1 and PCA3 may be utilized as therapeutic targets and prognostic biomarkers, respectively” Researchers, led by first author Parisa Najari and corresponding author Reza Safaralizadeh ...
BUFFALO, N.Y. -- A major limitation of treating breast cancer with a class of chemotherapeutic drugs known as anthracyclines is the development of cardiac damage in some patients. A team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback